Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Altmueller, Janine Dr.med. (3) Daniel, Peter Prof. Dr. (2) Kammertöns, Thomas Dr. (7) Kopp, Joachim Dr. (2) Lee, Young-Ae Prof. Dr. (1) Pezzutto, Antonio Prof. Dr. (3) Uckert, Wolfgang Prof. Dr. (3) (-) Blankenstein, Thomas Prof. Dr. (26) (-) Willimsky, Gerald Dr. (10) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) (-) 2002 (5) 2003 (9) 2004 (8) (-) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) (-) 2013 (12) 2014 (3) 2015 (4) 2016 (5) 2017 (6) 2018 (6) 2019 (7) 2020 (2) 2021 (4) 2022 (12) 2023 (10) 2024 (3) Developmental Biology / Signal Transduction (1) Experimental Ultrahigh-Field MR (1) Genetics of Metabolic and Reproductive Disorders (2) Magnetic Resonance (1) (-) Molecular Immunology and Gene Therapy (27) 27 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Willimsky, Gerald Dr.Molecular Immunology and Gene Therapy200220052013 Sort: Result score Newest to oldest Oldest to newest May 20, 2005 / Bioforum Gentherapie mit T-Zellrezeptor modifizierten Zellen W. Uckert T. Blankenstein July 01, 2005 / Hum Gene Ther Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes B. Engels E. Noessner B. Frankenberger T. Blankenstein D.J. Schendel W. Uckert July 05, 2005 / World J Urol Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells B. Frankenberger S. Regn C. Geiger E. Noessner C.S. Falk H. Pohla M. Javorovic T. Silberzahn S. Wilde A. Buchner M. Siebels R. Oberneder G. Willimsky A. Pezzutto T. Blankenstein D.J. Schendel September 01, 2005 / Nature Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance G. Willimsky T. Blankenstein January 01, 2005 / Int J Cancer Tumor-induced antibodies resemble the response to tissue damage S. Preiss T. Kammertoens C. Lampert G. Willimsky T. Blankenstein January 01, 2005 / Curr Opin Immunol The role of tumor stroma in the interaction between tumor and immune system T. Blankenstein January 01, 2005 / Clin Cancer Res Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs B. Frankenberger H. Pohla E. Noessner G. Willimsky B. Papier A. Pezzutto J. Kopp R. Oberneder T. Blankenstein D.J. Schendel January 01, 2005 / Int J Cancer Necrotic death but not irradiation abolishes costimulation of T-cell effector functions and survival by CD80-expressing tumor cells L. Staerck C. Scholz T. Blankenstein B. Doerken P.T. Daniel January 01, 2005 / Canc Res CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells T. Kammertoens R. Willebrand B. Erdmann L. Li Y. Li B. Engels W. Uckert T. Blankenstein April 01, 2002 / Trends Immunol Cross-priming versus cross-tolerance: are two signals enough? T. Blankenstein T. Schueler Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
May 20, 2005 / Bioforum Gentherapie mit T-Zellrezeptor modifizierten Zellen W. Uckert T. Blankenstein
July 01, 2005 / Hum Gene Ther Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes B. Engels E. Noessner B. Frankenberger T. Blankenstein D.J. Schendel W. Uckert
July 05, 2005 / World J Urol Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells B. Frankenberger S. Regn C. Geiger E. Noessner C.S. Falk H. Pohla M. Javorovic T. Silberzahn S. Wilde A. Buchner M. Siebels R. Oberneder G. Willimsky A. Pezzutto T. Blankenstein D.J. Schendel
September 01, 2005 / Nature Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance G. Willimsky T. Blankenstein
January 01, 2005 / Int J Cancer Tumor-induced antibodies resemble the response to tissue damage S. Preiss T. Kammertoens C. Lampert G. Willimsky T. Blankenstein
January 01, 2005 / Curr Opin Immunol The role of tumor stroma in the interaction between tumor and immune system T. Blankenstein
January 01, 2005 / Clin Cancer Res Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs B. Frankenberger H. Pohla E. Noessner G. Willimsky B. Papier A. Pezzutto J. Kopp R. Oberneder T. Blankenstein D.J. Schendel
January 01, 2005 / Int J Cancer Necrotic death but not irradiation abolishes costimulation of T-cell effector functions and survival by CD80-expressing tumor cells L. Staerck C. Scholz T. Blankenstein B. Doerken P.T. Daniel
January 01, 2005 / Canc Res CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells T. Kammertoens R. Willebrand B. Erdmann L. Li Y. Li B. Engels W. Uckert T. Blankenstein
April 01, 2002 / Trends Immunol Cross-priming versus cross-tolerance: are two signals enough? T. Blankenstein T. Schueler